Skip Navigation LinksHome > July 2013 - Volume 35 - Issue 5 > A Practical Strategy of Monitoring Minimal Residue Disease a...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e31829084eb
Clinical and Laboratory Observations

A Practical Strategy of Monitoring Minimal Residue Disease and Intervention for Central Nervous System Relapse of Childhood Acute Lymphoblastic Leukemia: A Single Chinese Center’s Experience

Liang, Yang MD, PhD*; Ca, Qing MD*,†; Zhai, Zhi-Min MD, PhD; Wang, Ning-Ling MD§

Collapse Box

Abstract

Objective:

To investigate monitoring minimal residual disease (MRD) using cerebral spinal fluid for predicting central nervous system leukemia (CNSL) and treatment.

Observations:

There is no survival difference between enhanced triple intrathecal therapy (ETIT) and cranial radiation for CNSL patients with positive morphology and MRD. Positive MRD correlated with CNSL, whereas negative MRD indicated a lower chance of CNSL recurrence. Altogether 79 cerebral spinal fluid specimens indicating negative morphology but positive MRD were given either ETIT or conventional triple intrathecal therapy. The ETIT group indicated lower relapse.

Conclusion:

Flow cytometry is sensitive to predict CNSL and ETIT is a potent intervention.

Copyright © 2013 by Lippincott Williams & Wilkins

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/JPHOonline

For additional oncology content, visit LWW Oncology Journals on Facebook.